Production (Stage)
Pharvaris N.V.
PHVS
$16.78
$0.734.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -163.68M | -145.33M | -143.53M | -123.36M | -115.19M |
| Total Depreciation and Amortization | 329.60K | 290.80K | 264.90K | 290.90K | 284.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.14M | 8.83M | 21.45M | 10.54M | 12.24M |
| Change in Net Operating Assets | 2.10M | 6.28M | 3.51M | 5.16M | 2.80M |
| Cash from Operations | -144.11M | -129.93M | -118.30M | -107.37M | -99.87M |
| Capital Expenditure | -720.90K | -584.80K | -443.90K | -115.30K | -110.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -720.90K | -584.80K | -443.90K | -115.30K | -110.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -210.40K | -159.70K | -187.80K | -237.60K | -217.60K |
| Issuance of Common Stock | 2.08M | 2.24M | 280.36M | 279.46M | 343.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.10K | 591.90K | -16.33M | -16.49M | -16.64M |
| Cash from Financing | 1.96M | 2.91M | 284.08M | 282.85M | 351.99M |
| Foreign Exchange rate Adjustments | 1.39M | 7.83M | -8.33M | 1.16M | -928.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.48M | -119.78M | 157.00M | 176.53M | 251.09M |